|
HL7 - Version 2.5 |
|
Interpretation: | Angaben zur Kausalität |
OID Table: | 2.16.840.1.113883.12.252 |
Codesystem OID: | 2.16.840.1.113883.18.147 Version 1 |
Value Set OID: | 2.16.840.1.113883.21.159 |
Binding: | universal |
Expansion: | all codes from codesystem |
Vocabulary Domain: | tbd |
Table Type: | HL7 |
Case insensitive: | Falsch |
Section | 7.12.3.22 |
Value | Description | German Interpretation | Comment | Chapter |
---|---|---|---|---|
AW | Abatement of event after product withdrawn | |||
BE | Event recurred after product reintroduced | |||
LI | Literature reports association of product with event | |||
IN | Event occurred after product introduced | |||
EX | Alternative explanations for the event available | |||
PL | Effect observed when patient receives placebo | |||
TC | Toxic levels of product documented in blood or body fluids | |||
DR | Dose response observed | |||
SE | Similar events in past for this patient | |||
OE | Occurrence of event was confirmed by objective evidence | |||
OT | Other |
Links to Other/Further HL7 Information | generated: Aug 07, 2023 (FO) | |||
Health Level Seven, Int. (HQ) |
HL7 Germany HL7 Europe |
Frank Oemig's HL7 Site (Infos about the database) |
HL7-Experts Network |